Mobile Peer Support for OUD Recovery
Launched by BROWN UNIVERSITY · Jun 2, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new mobile app designed to support people recovering from opioid use disorder (OUD). The goal is to see if this app can help individuals stay in treatment longer and improve their overall well-being, especially during the challenges brought on by the COVID-19 pandemic, such as reduced access to care and increased stress. By comparing the app to standard care, researchers hope to find out how effective this digital support can be in helping people on their recovery journey.
To participate in this study, you need to be at least 18 years old, speak English, and own a smartphone that runs on Android or iOS. You should also identify as being in recovery from or currently receiving treatment for opioid use disorder. If you're interested, you can expect to use the app and share your experiences to help researchers understand its impact. This study is currently looking for participants, and your involvement could lead to a valuable resource for others facing similar challenges in their recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • English-speaking
- • Age ≥ 18 years old
- • Own their own smartphone
- • Self-identifying as being in recovery from or treatment for an opioid use disorder
- Exclusion Criteria:
- • Does not have an Android or iOS platform smartphone
- • Previous enrollment in the study
- • Currently incarcerated
- • Unable to provide informed consent
About Brown University
Brown University, a prestigious Ivy League institution located in Providence, Rhode Island, is committed to advancing medical research and improving public health through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Brown leverages its world-class faculty and state-of-the-art facilities to conduct rigorous studies across various fields, including medicine, public health, and biomedical sciences. The university's dedication to ethical research practices and participant safety ensures that all clinical trials are designed to yield meaningful insights that contribute to the development of new therapies and health interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Providence, Rhode Island, United States
Patients applied
Trial Officials
Megan Ranney, MD, MPH
Principal Investigator
Brown University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials